Fingerprint
Dive into the research topics of 'A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A. B. El-Khoueiry, R. K. Ramanathan, D. Y. Yang, W. Zhang, S. Shibata, J. J. Wright, D. Gandara, H. J. Lenz
Research output: Contribution to journal › Article › peer-review